Jun Adachi Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

1/2021

Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Adachi Research Topics

Disease

19	Neoplasms (Cancer) 04/2024 - 01/2009
11	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2009
5	Inflammation (Inflammations) 01/2024 - 01/2019
4	Contact Dermatitis (Eczema, Contact) 01/2022 - 01/2019
4	Breast Neoplasms (Breast Cancer) 01/2015 - 08/2012
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 08/2021
3	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 04/2021
3	Carcinogenesis 01/2022 - 01/2015
3	Neoplasm Metastasis (Metastasis) 01/2015 - 01/2009
2	Lung Neoplasms (Lung Cancer) 04/2024 - 03/2022
2	Pathologic Processes 11/2022 - 12/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 11/2017
2	Rare Diseases (Rare Disease) 11/2020 - 12/2013
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2015
1	Asthma (Bronchial Asthma) 03/2024
1	Nasal Polyps (Nasal Polyp) 03/2024
1	Rhinosinusitis 03/2024
1	Idiopathic Pulmonary Fibrosis 01/2024
1	Fibrosis (Cirrhosis) 01/2024
1	Respiratory Sounds (Crackle) 01/2024
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2023
1	Adenocarcinoma of Lung 01/2023
1	Leukemia 01/2023
1	Genomic Instability 01/2023
1	Skin Diseases (Skin Disease) 12/2022
1	COVID-19 11/2022
1	Chronic Hepatitis C 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Sarcoidosis (Schaumann Disease) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2021
1	Mouth Neoplasms (Oral Cancer) 07/2021
1	Emphysema 01/2021
1	Hyperglycemia 01/2021

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2007
16	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2011
5	Phosphotransferases (Kinase)IBA 07/2021 - 08/2013
3	Membrane Proteins (Integral Membrane Proteins)IBA 10/2022 - 01/2013
3	LipidsIBA 01/2022 - 11/2019
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2017
3	Keratins (Keratin)IBA 09/2016 - 10/2013
3	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 01/2009
2	ProteomeIBA 01/2024 - 01/2015
2	PhosphoproteinsIBA 01/2023 - 06/2013
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 07/2021
2	EnzymesIBA 10/2022 - 08/2021
2	lorlatinibIBA 03/2022 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2021
2	12-hydroxy-5,8,10,14,17-eicospentaenoic acidIBA 01/2021 - 01/2021
2	Linseed Oil (Flaxseed Oil)IBA 01/2021 - 11/2019
2	Triglycerides (Triacylglycerol)IBA 11/2020 - 12/2013
2	PhosphotyrosineIBA 01/2017 - 01/2017
2	Casein Kinases (Casein Kinase)IBA 09/2016 - 10/2013
2	Polysaccharides (Glycans)IBA 01/2016 - 01/2016
2	Monoclonal AntibodiesIBA 01/2016 - 01/2016
2	AntigensIBA 01/2016 - 01/2016
1	osimertinibIBA 04/2024
1	Eosinophil PeroxidaseIBA 03/2024
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2024
1	Complement System Proteins (Complement)IBA 01/2024
1	Antifungal AgentsIBA 02/2023
1	Itraconazole (Sporanox)FDA LinkGeneric 02/2023
1	Tight Junction ProteinsIBA 01/2023
1	Histone MethyltransferasesIBA 01/2023
1	HeterochromatinIBA 01/2023
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2023
1	nuclear pore complex protein 98IBA 01/2023
1	apatinibIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	EphrinsIBA 10/2022
1	ImmunosorbentsIBA 10/2022
1	Anaplastic Lymphoma KinaseIBA 03/2022
1	Collagen Type IV (Type IV Collagen)IBA 01/2022
1	HaptensIBA 01/2022
1	lipopolysaccharide-binding proteinIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Serum Amyloid P-ComponentIBA 01/2022
1	PlatinumIBA 08/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2021
1	Cisplatin (Platino)FDA LinkGeneric 08/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2021
1	130-nm albumin-bound paclitaxelIBA 08/2021
1	pevonedistatIBA 08/2021
1	Capecitabine (Xeloda)FDA Link 08/2021
1	Tyrosine (L-Tyrosine)FDA Link 07/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2021
1	purineIBA 07/2021
1	Nucleic AcidsIBA 04/2021
1	locked nucleic acidIBA 04/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	ElastinIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	entrectinibIBA 01/2021

Therapy/Procedure

3	Therapeutics 12/2020 - 01/2015
1	Molecular Targeted Therapy 04/2024